Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
CNS Drugs
Published in: CNS Drugs 4/1999

01-04-1999 | Disease Management

Guidelines for the Appropriate Use of Cholinesterase Inhibitors in Patients with Alzheimer’s Disease

Authors: Dr Armand S. Schachter, Kenneth L. Davis

Published in: CNS Drugs | Issue 4/1999

Login to get access
Metadata
Title
Guidelines for the Appropriate Use of Cholinesterase Inhibitors in Patients with Alzheimer’s Disease
Authors
Dr Armand S. Schachter
Kenneth L. Davis
Publication date
01-04-1999
Publisher
Springer International Publishing
Published in
CNS Drugs / Issue 4/1999
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI
https://doi.org/10.2165/00023210-199911040-00004

Other articles of this Issue 4/1999

CNS Drugs 4/1999 Go to the issue

Review Article

Predicting Response to Clozapine

Disease Management

Glatiramer Acetate or Interferon-β for Multiple Sclerosis?

Disease Management

Hypnosedatives in the Elderly

Current Opinion

Provision of Diamorphine (Heroin) by Prescription for Drug Dependency

Review Article

Selective Serotonin Reuptake Inhibitors in the Treatment of Social Phobia

Leading Article

Do Glucocorticoids Have Adverse Effects on Brain Function?